PDS Biotechnology Corporation - Common Stock (NQ:PDSB)
1.110
+0.010
(+0.91%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 27, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 921,283 |
| Open | 1.130 |
| Bid (Size) | 1.140 (200) |
| Ask (Size) | 1.150 (100) |
| Prev. Close | 1.100 |
| Today's Range | 1.050 - 1.140 |
| 52wk Range | 0.5068 - 1.915 |
| Shares Outstanding | 28,458,688 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
| YTD |
+33.2%
|
+33.2%
|
| 1 Month |
+19.4%
|
+19.4%
|
| 3 Month |
+68.4%
|
+68.4%
|
| 6 Month |
+48.9%
|
+48.9%
|
| 1 Year |
-22.4%
|
-22.4%
|
Frequently Asked Questions
Is PDS Biotechnology Corporation - Common Stock publicly traded?
Yes, PDS Biotechnology Corporation - Common Stock is publicly traded.
What exchange does PDS Biotechnology Corporation - Common Stock trade on?
PDS Biotechnology Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for PDS Biotechnology Corporation - Common Stock?
The ticker symbol for PDS Biotechnology Corporation - Common Stock is PDSB on the Nasdaq Stock Market
What is the current price of PDS Biotechnology Corporation - Common Stock?
The current price of PDS Biotechnology Corporation - Common Stock is 1.110
When was PDS Biotechnology Corporation - Common Stock last traded?
The last trade of PDS Biotechnology Corporation - Common Stock was at 05/27/26 04:00 PM ET
What is the market capitalization of PDS Biotechnology Corporation - Common Stock?
The market capitalization of PDS Biotechnology Corporation - Common Stock is 31.59M
How many shares of PDS Biotechnology Corporation - Common Stock are outstanding?
PDS Biotechnology Corporation - Common Stock has 32M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>